Clinical Trial Update: Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating trimetazidine for myocardial injury after PCI in patients with angina and diabetes is in progress, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Diabetes Mellitus

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Diabetes Mellitus, Angina, Unstable | Phase 3 | Status: UNKNOWN